Premium
Origin and spread of a common deletion causing mucolipidosis type II: insights from patterns of haplotypic diversity
Author(s) -
Coutinho MF,
Encarnação M,
Gomes R,
da Silva Santos L,
Martins S,
SiroisGag D,
Bargal R,
Filocamo M,
RaasRothschild A,
Tappino B,
Laprise C,
Cury GK,
Schwartz IV,
Artigalás O,
Prata MJ,
Alves S
Publication year - 2011
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/j.1399-0004.2010.01539.x
Subject(s) - haplotype , genetics , mucolipidosis , founder effect , mutation , biology , genotype , microbiology and biotechnology , gene , enzyme , biochemistry
Coutinho MF, Encarnação M, Gomes R, da Silva Santos L, Martins S, Sirois‐Gagnon D, Bargal R, Filocamo M, Raas‐Rothschild A, Tappino B, Laprise C, Cury GK, Schwartz IV, Artigalás O, Prata MJ, Alves S. Origin and spread of a common deletion causing mucolipidosis type II: insights from patterns of haplotypic diversity. Mucolipidosis II (ML II alpha/beta), or I‐cell disease, is a rare genetic disease in which activity of the uridine diphosphate (UDP)‐ N ‐acetylglucosamine:lysosomal enzyme N ‐acetylglucosamine‐1‐phosphotransferase (GlcNAc‐phosphotransferase) is absent. GlcNAc‐phosphotransferase is a multimeric enzyme encoded by two genes, GNPTAB and GNPTG . A spectrum of mutations in GNPTAB has been recently reported to cause ML II alpha/beta. Most of these mutations were found to be private or rare. However, the mutation c.3503_3504delTC has been detected among Israeli and Palestinian Arab‐Muslim, Turkish, Canadian, Italian, Portuguese, Irish traveller and US patients. We analysed 44 patients who were either homozygous or compound heterozygous for this deletion (22 Italians, 8 Arab‐Muslims, 1 Turk, 3 Argentineans, 3 Brazilians, 2 Irish travellers and 5 Portuguese) and 16 carriers (15 Canadians and 1 Italian) for three intragenic polymorphisms: c.‐41_‐39delGGC, c.18G>A and c.1932A>G as well as two microsatellite markers flanking the GNPTAB gene (D12S1607 and D12S1727). We identified a common haplotype in all chromosomes bearing the c.3503_3504delTC mutation. In summary, we showed that patients carrying the c.3503_3504delTC deletion presented with a common haplotype, which implies a common origin of this mutation. Additionally, the level of diversity observed at the most distant locus indicates that the mutation is relatively ancient (around 2063 years old), and the geographical distribution further suggests that it probably arose in a peri‐Mediterranean region.